$PLL
Piedmont Lithium Inc.

2022 Q3 Form 10-Q Financial Statement

#000172820522000034 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $7.271M $7.675M $5.615M
YoY Change -17.87%
% of Gross Profit
Research & Development $302.8K $662.9K $126.0K
YoY Change -93.61%
% of Gross Profit
Depreciation & Amortization $21.27K $6.146K $5.062K
YoY Change 469.7% 346.66% 267.88%
% of Gross Profit
Operating Expenses $7.595M $8.344M $5.746M
YoY Change -26.85% -57.72%
Operating Profit -$9.597M -$8.344M -$5.746M
YoY Change -7.56% 11.56% -11.74%
Interest Expense $20.64K -$33.93K -$42.40K
YoY Change -134.95% -46.33% -35.64%
% of Operating Profit
Other Income/Expense, Net $29.68M -$81.69K -$19.29K
YoY Change -43030.0%
Pretax Income $20.10M -$9.600M -$9.200M
YoY Change -291.43% 26.32% 39.39%
Income Tax $3.400M $0.00 $0.00
% Of Pretax Income 16.92%
Net Earnings $16.66M -$9.581M -$9.155M
YoY Change -253.43% 25.53% 39.21%
Net Earnings / Revenue
Basic Earnings Per Share $0.93 -$0.53 -$0.57
Diluted Earnings Per Share $0.92 -$0.53 -$0.57
COMMON SHARES
Basic Shares Outstanding 17.96M shares 17.93M shares 16.09M shares
Diluted Shares Outstanding 18.08M shares 17.93M shares 16.09M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $117.6M $139.0M $166.4M
YoY Change -2.54%
Cash & Equivalents $117.6M $139.0M $165.9M
Short-Term Investments $534.3K
Other Short-Term Assets $3.362M $4.460M
YoY Change 36.18% 256.45%
Inventory
Prepaid Expenses $1.083M
Receivables
Other Receivables
Total Short-Term Assets $121.0M $143.5M $167.5M
YoY Change 43.27% -0.28%
LONG-TERM ASSETS
Property, Plant & Equipment $64.34M $53.69M $48.13M
YoY Change 8523.55% 7297.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $96.83M $64.23M $57.72M
YoY Change 65.42% 294.98% 519.59%
Other Assets $15.73M $11.62M $8.131M
YoY Change 7514.49% 5119.86%
Total Long-Term Assets $176.9M $129.6M $114.0M
YoY Change 85.0% 194.78%
TOTAL ASSETS
Total Short-Term Assets $121.0M $143.5M $167.5M
Total Long-Term Assets $176.9M $129.6M $114.0M
Total Assets $297.9M $273.0M $281.5M
YoY Change 65.43% 45.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.959M $1.613M $1.522M
YoY Change -30.84% -37.04%
Accrued Expenses $4.665M $3.991M $3.736M
YoY Change 27.21% 66.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $458.6K $504.9K $722.3K
YoY Change -64.38% -53.48%
Total Short-Term Liabilities $7.202M $6.139M $6.040M
YoY Change -9.15% -1.22%
LONG-TERM LIABILITIES
Long-Term Debt $244.7K $349.4K $706.8K
YoY Change -77.18% -71.51%
Other Long-Term Liabilities $1.210M
YoY Change
Total Long-Term Liabilities $244.7K $349.4K $706.8K
YoY Change -77.18% -71.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.202M $6.139M $6.040M
Total Long-Term Liabilities $244.7K $349.4K $706.8K
Total Liabilities $12.47M $6.488M $6.746M
YoY Change 38.56% -12.8%
SHAREHOLDERS EQUITY
Retained Earnings -$94.80M -$111.4M -$101.8M
YoY Change 15.33% 56.24%
Common Stock $1.799K $1.796K $1.793K
YoY Change 15.32% 15.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $285.4M $266.6M $274.8M
YoY Change
Total Liabilities & Shareholders Equity $297.9M $273.0M $281.5M
YoY Change 65.43% 45.35%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $16.66M -$9.581M -$9.155M
YoY Change -253.43% 25.53% 39.21%
Depreciation, Depletion And Amortization $21.27K $6.146K $5.062K
YoY Change 469.7% 346.66% 267.88%
Cash From Operating Activities -$4.188M $50.00K -$8.849M
YoY Change -54.8% -100.31% 175.07%
INVESTING ACTIVITIES
Capital Expenditures $14.39M -$13.92M $5.619M
YoY Change 59873.74% -23.53% 10.38%
Acquisitions
YoY Change
Other Investing Activities -$2.716M -$3.467M -$3.632M
YoY Change -78.81%
Cash From Investing Activities -$17.11M -$17.39M -$11.30M
YoY Change -66.98% -49.69% -21.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $122.1M
YoY Change 6.99%
Debt Paid & Issued, Net $247.2K
YoY Change 35.12%
Cash From Financing Activities -151.0K -481.5K $121.8M
YoY Change -141.44% -100.28% 6.91%
NET CHANGE
Cash From Operating Activities -4.188M 50.00K -$8.849M
Cash From Investing Activities -17.11M -17.39M -$11.30M
Cash From Financing Activities -151.0K -481.5K $121.8M
Net Change In Cash -21.44M 50.00K $101.7M
YoY Change -64.67% -99.96% 5.56%
FREE CASH FLOW
Cash From Operating Activities -$4.188M $50.00K -$8.849M
Capital Expenditures $14.39M -$13.92M $5.619M
Free Cash Flow -$18.58M $13.97M -$14.47M
YoY Change 100.0% 616.55% 74.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001728205
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q2 pll Chess Depository Interests Exchange Ratio
ChessDepositoryInterestsExchangeRatio
0.01
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38427
dei Entity Registrant Name
EntityRegistrantName
PIEDMONT LITHIUM INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4996461
dei Entity Address Address Line1
EntityAddressAddressLine1
42 E Catawba Street
dei Entity Address Address Line2
EntityAddressAddressLine2
dei Entity Address City Or Town
EntityAddressCityOrTown
Belmont
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28012
dei City Area Code
CityAreaCode
704
dei Local Phone Number
LocalPhoneNumber
461-8000
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
PLL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17964863 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139033696 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64244983 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4460334 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2514602 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
143494030 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
66759585 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53693669 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40055354 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11624524 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4561122 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
64233609 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
58872710 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13989767 usd
CY2022Q2 us-gaap Assets
Assets
273045832 usd
CY2021Q4 us-gaap Assets
Assets
170248771 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1613013 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1262744 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3990970 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5425498 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
504855 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
762189 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29906 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
99587 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6138744 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7550018 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
349415 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
914147 usd
CY2022Q2 us-gaap Liabilities
Liabilities
6488159 usd
CY2021Q4 us-gaap Liabilities
Liabilities
8464165 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15894395 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15894395 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1796 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1589 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
378789754 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
255131836 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111418935 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92683000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-814942 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-665819 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
266557673 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
161784606 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
273045832 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
170248771 usd
CY2022Q2 pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
882874 usd
CY2021Q2 pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
3477327 usd
pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
1050712 usd
pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
7302336 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7461365 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4002054 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13039370 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6687431 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8344239 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7479381 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14090082 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-33926 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-63216 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-76322 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-129085 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-47759 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-25749 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24649 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-25532 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8425924 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7568346 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14191053 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14144384 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1155379 usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64626 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4544882 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64626 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9581303 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7632972 usd
us-gaap Net Income Loss
NetIncomeLoss
-18735935 usd
us-gaap Net Income Loss
NetIncomeLoss
-14209010 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17930926 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17930926 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15753324 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15753324 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17019262 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17019262 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14926734 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14926734 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9581303 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7632972 usd
us-gaap Net Income Loss
NetIncomeLoss
-18735935 usd
us-gaap Net Income Loss
NetIncomeLoss
-14209010 usd
CY2022Q2 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-342767 usd
CY2021Q2 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-31288 usd
us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-149123 usd
us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-31288 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-342767 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31288 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-149123 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31288 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9924070 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7664260 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18885058 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14240298 usd
us-gaap Net Income Loss
NetIncomeLoss
-18735935 usd
us-gaap Net Income Loss
NetIncomeLoss
-14209010 usd
us-gaap Depreciation
Depreciation
11208 usd
us-gaap Depreciation
Depreciation
2752 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1382905 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1018296 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
60919 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
74979 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11542 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-23824 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4544882 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64626 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1969142 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1172736 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-486145 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
305200 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2697909 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1192448 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17853851 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12723445 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11533913 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13136824 usd
pll Advances Paid On Equity Method Investment
AdvancesPaidOnEquityMethodInvestment
7099355 usd
pll Advances Paid On Equity Method Investment
AdvancesPaidOnEquityMethodInvestment
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
10054904 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
16358412 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28688172 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29495236 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
122059476 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
114087891 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
93326 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
216151 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
822066 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
370707 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
121330736 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113933335 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
74788713 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
71714654 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64244983 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70936994 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139033696 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142651648 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2004734 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Interest Paid Net
InterestPaidNet
76612 usd
us-gaap Interest Paid Net
InterestPaidNet
68838 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
122418 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
161784606 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
122059476 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-85908 usd
CY2022Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
193644 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9154632 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
274797186 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1591231 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
93326 usd
CY2022Q2 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-342767 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9581303 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
266557673 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
79328671 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
114087891 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
180410711 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
406488 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30452 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6576038 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
187277464 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
611808 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
185699 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31288 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7632972 usd
CY2021Q2 us-gaap Shares Outstanding
SharesOutstanding
15764533 shares
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Fiscal Year-End</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2022, we changed our fiscal year end from June 30 to December 31. The six-month period from July 1, 2021 to December 31, 2021 served as a transition period. Our fiscal year for 2022 commenced on January 1, 2022 and will end on December 31, 2022. See our Transition Report on Form 10-KT (“Transition Report”) filed with the Securities and Exchange Commission (the “SEC”) on February 28, 2022.</span></div>
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111400000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92700000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our estimates and assumptions on current facts, historical experience and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></div>
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53716997 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40099120 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23328 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43766 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53693669 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40055354 usd
CY2022Q2 us-gaap Depreciation
Depreciation
6146 usd
CY2021Q2 us-gaap Depreciation
Depreciation
1376 usd
us-gaap Depreciation
Depreciation
11208 usd
us-gaap Depreciation
Depreciation
2752 usd
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
57723058 usd
CY2022Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
8008697 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1155379 usd
CY2022Q2 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-342767 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
64233609 usd
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
9316394 usd
CY2021Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
7042018 usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64626 usd
CY2021Q2 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-31288 usd
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
16262498 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
58872710 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
10054904 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4544882 usd
CY2022Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
489687 usd
us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-149123 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
64233609 usd
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
16358412 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64626 usd
us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-31288 usd
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
16262498 usd
CY2022Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
900000 usd
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1700000 usd
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
513511 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3970647 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2001091 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4460334 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2514602 usd
CY2022Q2 pll Equity Method Investment Advances
EquityMethodInvestmentAdvances
11409528 usd
CY2021Q4 pll Equity Method Investment Advances
EquityMethodInvestmentAdvances
4310173 usd
CY2022Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
214996 usd
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
190030 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
60919 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11624524 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4561122 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9600000 usd
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
8800000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1591231 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
611808 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2012500 shares
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
65.00
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
130800000 usd
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1750000 shares
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
70.00
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
122500000 usd
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12800000 usd
CY2022Q2 pll Capital Shares Reserved For Future Issuance Amount
CapitalSharesReservedForFutureIssuanceAmount
369200000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1591231 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
611808 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1505323 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2356086 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1018296 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
850763 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1018296 usd
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
-1510671 usd
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
-611808 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
-1382905 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
-1018296 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
80560 usd
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
122418 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-1591231 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-611808 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-1505323 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-1018296 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
272504 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
443694 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
135957 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000 shares
CY2022Q1 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
15000 shares
CY2021Q1 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
18906 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
19458 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
374003 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
474788 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58949 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
33004 shares
CY2022Q2 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
37500 shares
CY2021Q2 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
115288 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
719 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
394733 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
392504 shares
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7700000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9581303 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9581303 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7632972 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7632972 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18735935 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18735935 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14209010 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14209010 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17930926 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17930926 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15753324 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15753324 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17019262 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17019262 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14926734 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14926734 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500174 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
489249 shares
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14200000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0

Files In Submission

Name View Source Status
R22.htm Edgar Link pending
0001728205-22-000034-index-headers.html Edgar Link pending
0001728205-22-000034-index.html Edgar Link pending
0001728205-22-000034.txt Edgar Link pending
0001728205-22-000034-xbrl.zip Edgar Link pending
ex3111.htm Edgar Link pending
ex3121.htm Edgar Link pending
ex3211.htm Edgar Link pending
ex3221.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lithiummarketgrapha02.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pll-20220630.htm Edgar Link pending
pll-20220630.xsd Edgar Link pending
pll-20220630_cal.xml Edgar Link unprocessable
pll-20220630_def.xml Edgar Link unprocessable
pll-20220630_g1.jpg Edgar Link pending
pll-20220630_htm.xml Edgar Link completed
pll-20220630_lab.xml Edgar Link unprocessable
pll-20220630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending